Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency

Mitochondrion. 2017 May:34:84-90. doi: 10.1016/j.mito.2017.02.004. Epub 2017 Feb 12.

Abstract

We report the clinical, biochemical, and molecular findings in two brothers with encephalopathy and multi-systemic disease. Abnormal transferrin glycoforms were suggestive of a type I congenital disorder of glycosylation (CDG). While exome sequencing was negative for CDG related candidate genes, the testing revealed compound heterozygous mutations in the mitochondrial elongation factor G gene (GFM1). One of the mutations had been reported previously while the second, novel variant was found deep in intron 6, activating a cryptic splice site. Functional studies demonstrated decreased GFM1 protein levels, suggested disrupted assembly of mitochondrial complexes III and V and decreased activities of mitochondrial complexes I and IV, all indicating combined OXPHOS deficiency.

Keywords: Congenital disorders of glycosylation; Cryptic splice site; GFM1; Mitochondrial disease; Mitochondrial elongation factor.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child, Preschool
  • Congenital Abnormalities / genetics*
  • Congenital Abnormalities / pathology*
  • Gene Expression*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mitochondrial Proteins / biosynthesis*
  • Mitochondrial Proteins / genetics*
  • Oxidative Phosphorylation*
  • Peptide Elongation Factor G / biosynthesis*
  • Peptide Elongation Factor G / genetics*
  • RNA Splice Sites*

Substances

  • GFM1 protein, human
  • Mitochondrial Proteins
  • Peptide Elongation Factor G
  • RNA Splice Sites